HDAX Therapeutics
Elvin de Araujo, PhD is currently serving as the Co-Founder at HDAX Therapeutics since August 2021. Prior to this role, Elvin was the Research Manager at the Centre for Medicinal Chemistry at the University of Toronto since 2019.
This person is not in any teams
HDAX Therapeutics
Pioneering next-gen precision therapeutics for diseases stemming from microtubule dysfunction, such as neuropathies and cardiovascular diseases.